ATRC — AtriCure, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1323885 ·
Last close
$58.41
Market Cap
$2.97B
52W High
$61.70
52W Low
$25.36
ADV30
1,288,362
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 141,249,000 | 109,311,000 | 526,000 | 108,000 | 643,988,000 | 146,165,000 | 152,295,000 |
| Dec 2025 | 140,500,000 | 105,337,000 | 2,491,000 | 1,756,000 | 654,179,000 | 167,428,000 | 162,244,000 |
| Sep 2025 | 134,269,000 | 101,332,000 | 208,000 | -267,000 | 635,442,000 | 147,865,000 | 158,935,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$64,939,000
Investing CF
$-12,825,000
Financing CF
$-1,911,000
CapEx
$-12,825,000
Dividends Paid
$0
Buybacks
$-12,341,000
EPS Diluted TTM
$0.21
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-404,140,000
Inventory
$83,925,000
Receivables
$79,981,000
ST Investments
$0
EBIT TTM
$17,724,000
Pretax Income TTM
$12,094,000
Interest Exp TTM
$5,630,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$569,622,016
EBITDA
$33,746,000
Free Cash Flow
$48,811,500
Enterprise Value
$2,680,682,752
Total Cash
$167,786,000
Total Debt
$74,221,000
Shares Out
50,866,294
Trailing EPS
$0.21
Book Value
$10.15
ROE
2.2%
ROA
1.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 534,528,000 | -9,447,000 | — | 654,179,000 | 162,244,000 | 491,935,000 | 57,334,000 |
| Dec 2024 | 465,307,000 | -40,013,000 | -44,698,000 | 609,328,000 | 148,359,000 | 460,969,000 | 12,204,000 |
| Dec 2023 | 399,245,000 | -26,683,000 | -30,438,000 | 613,932,000 | 147,764,000 | 466,168,000 | 4,484,000 |
| Dec 2022 | 330,379,000 | -42,669,000 | -46,466,000 | 585,448,000 | 128,694,000 | 456,754,000 | -22,141,000 |
| Dec 2021 | — | — | 50,199,000 | — | — | — | — |
TTM Snapshot
Revenues TTM
$421,066,000
NetIncome TTM
$-35,927,000
OpCashFlow TTM
$0
Assets (Latest)
$654,179,000
Forward EPS
$0.43
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $40.00 · spot: $58.41 · call volume: 119 · put volume: 11
Expected Move to 2026-10-16:
±$4.60
(7.88%) —
implied range
$53.81 –
$63.01
· ATM straddle on $60.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TMDX | TransMedics Group, Inc. | $2.87B | $82.73 | — |
| IRTC | iRhythm Holdings, Inc. | $3.71B | $112.60 | — |
| PLSE | PULSE BIOSCIENCES, INC. | $3.73B | $52.32 | — |
| AXGN | Axogen, Inc. | $2.33B | $43.36 | — |
| UFPT | UFP TECHNOLOGIES INC | $2.32B | $299.22 | — |
News headlines (Yahoo Finance, 1h cache)
Why AtriCure (ATRC) Is Back In The Spotlight
2026-09-25 17:14 · Yahoo
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
2026-09-14 13:40 · Yahoo
AtriCure CTO Sells 3,657 Shares
2026-09-13 00:05 · Yahoo
Do Options Traders Know Something About AtriCure Stock We Don't?
2026-09-10 14:39 · Yahoo
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue?
2026-09-09 19:53 · Yahoo
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?
2026-08-27 13:40 · Yahoo
Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic
2026-08-26 11:57 · Yahoo
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
2026-08-25 12:00 · Yahoo
AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth
2026-08-12 02:04 · Yahoo
An AtriCure Director Sold $905,000 in Stock. Here's How to Read It
2026-08-07 22:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.